XML 30 R19.htm IDEA: XBRL DOCUMENT v3.21.1
Business Segments
 3 Months Ended
Apr. 03, 2021
Segment Reporting [Abstract]  
Business Segments

12. Business Segments

The Company operates in one segment, ophthalmology. The Company develops, manufactures and markets medical devices. Our revenues arise from the sale of consoles, delivery devices, consumables, service, and support activities.

Revenue information shown by product group is as follows:

 

 

Three Months Ended

 

(in thousands)

April 3, 2021

 

 

March 28, 2020

 

Cyclo G6

$

3,349

 

 

$

2,923

 

Retina

 

6,660

 

 

 

4,134

 

Other(1)

 

1,950

 

 

 

1,964

 

Total revenues

$

11,959

 

 

$

9,021

 

(1) Includes service contract revenues of $299 and $315 recognized during the three months ended April 3, 2021 and March 28, 2020, respectively. Other also includes revenues from paid service, royalty, freight and legacy G probes.

 

 

Revenue information shown by geographic region, based on the sales destination, is as follows:

 

 

Three Months Ended

 

(in thousands)

April 3, 2021

 

 

March 28, 2020

 

United States

$

5,564

 

 

$

4,441

 

Europe

 

2,417

 

 

 

1,984

 

Rest of Americas

 

804

 

 

 

403

 

Asia/Pacific Rim

 

3,174

 

 

 

2,193

 

Total revenues

$

11,959

 

 

$

9,021

 

 

Revenues are attributed to countries based on the location of end customers.

Other than the United States, Japan accounted for more than 10% of the Company’s revenues during the three months ended April 3, 2021, representing 17%.   Other than the United States, Japan accounted for more than 10% of the Company’s revenues during the three months ended March 28, 2020, representing 13%. The United States accounted for 46.5% and 49.2% of revenues for the three months ended April 3, 2021 and March 28, 2020, respectively. International sales accounted for 53.5% and 50.8% of revenues for the three months ended April 3, 2021 and March 28, 2020, respectively.